
The relationship between diabetes zzso and risk of inappropriate or appropriate therapy in patients receiving an zzso zzso zzso and zzso therapy has not been investigated zzso The effect of innovative zzso programming on therapy delivery in these patients is zzso 

The zzso Automatic zzso zzso zzso zzso zzso zzso zzso patients with a primary zzso zzso indication to 3 different types of zzso zzso conventional programming with a zzso zzso zone of 170 to 199 zzso zzso zzso zzso zzso with a zzso zzso zone zzso zzso zzso B), or zzso therapy zzso zzso The end points of inappropriate therapy, appropriate therapy, and death were assessed among zzso patients with and zzso without diabetes zzso Innovative zzso programming reduced the risk of inappropriate therapy regardless of diabetes zzso although a trend toward a more pronounced effect of zzso zzso programming was seen in patients without diabetes zzso zzso for zzso Diabetes zzso was associated with a decreased risk of inappropriate therapy zzso ratio, zzso zzso confidence zzso zzso zzso and increased risk of appropriate therapy zzso ratio, zzso zzso confidence zzso zzso zzso In diabetic patients, there was significantly increased risk of death in those who had inappropriate therapy zzso ratio, zzso zzso confidence zzso zzso zzso and appropriate therapy zzso ratio, zzso zzso confidence zzso zzso zzso compared with those who did zzso 

Innovative zzso zzso or delayed zzso programming was associated with a reduction in inappropriate therapy in patients with and without diabetes zzso Diabetes zzso was associated with lower risk of inappropriate therapy but higher risk of appropriate zzso zzso and inappropriate zzso therapy was associated with increased mortality in diabetic zzso 

zzso zzso zzso zzso zzso 

